newsfilter
← Latest News
PR Newswire·

BioMarin Announces Close of the Alesta Therapeutics Acquisition

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Alesta Therapeutics. The...